198 related articles for article (PubMed ID: 15718413)
21. Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature.
Salaverria I; Zettl A; Beà S; Moreno V; Valls J; Hartmann E; Ott G; Wright G; Lopez-Guillermo A; Chan WC; Weisenburger DD; Gascoyne RD; Grogan TM; Delabie J; Jaffe ES; Montserrat E; Muller-Hermelink HK; Staudt LM; Rosenwald A; Campo E
J Clin Oncol; 2007 Apr; 25(10):1216-22. PubMed ID: 17296973
[TBL] [Abstract][Full Text] [Related]
22. TP53 mutations are common in mantle cell lymphoma, including the indolent leukemic non-nodal variant.
Sakhdari A; Ok CY; Patel KP; Kanagal-Shamanna R; Yin CC; Zuo Z; Hu S; Routbort MJ; Luthra R; Medeiros LJ; Khoury JD; Loghavi S
Ann Diagn Pathol; 2019 Aug; 41():38-42. PubMed ID: 31132650
[TBL] [Abstract][Full Text] [Related]
23. Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group.
Le Bris Y; Magrangeas F; Moreau A; Chiron D; Guérin-Charbonnel C; Theisen O; Pichon O; Canioni D; Burroni B; Maisonneuve H; Thieblemont C; Oberic L; Gyan E; Pellat-Deceunynck C; Hermine O; Delfau-Larue MH; Tessoulin B; Béné MC; Minvielle S; Le Gouill S
Hematol Oncol; 2020 Oct; 38(4):446-455. PubMed ID: 32472610
[TBL] [Abstract][Full Text] [Related]
24. Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations.
Sander S; Bullinger L; Leupolt E; Benner A; Kienle D; Katzenberger T; Kalla J; Ott G; Müller-Hermelink HK; Barth TF; Möller P; Lichter P; Döhner H; Stilgenbauer S
Haematologica; 2008 May; 93(5):680-7. PubMed ID: 18367489
[TBL] [Abstract][Full Text] [Related]
25. Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma.
Greiner TC; Dasgupta C; Ho VV; Weisenburger DD; Smith LM; Lynch JC; Vose JM; Fu K; Armitage JO; Braziel RM; Campo E; Delabie J; Gascoyne RD; Jaffe ES; Muller-Hermelink HK; Ott G; Rosenwald A; Staudt LM; Im MY; Karaman MW; Pike BL; Chan WC; Hacia JG
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2352-7. PubMed ID: 16461462
[TBL] [Abstract][Full Text] [Related]
26. High-resolution genomic screening in mantle cell lymphoma--specific changes correlate with genomic complexity, the proliferation signature and survival.
Halldórsdóttir AM; Sander B; Göransson H; Isaksson A; Kimby E; Mansouri M; Rosenquist R; Ehrencrona H
Genes Chromosomes Cancer; 2011 Feb; 50(2):113-21. PubMed ID: 21117067
[TBL] [Abstract][Full Text] [Related]
27. A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial.
Bomben R; Ferrero S; D'Agaro T; Dal Bo M; Re A; Evangelista A; Carella AM; Zamò A; Vitolo U; Omedè P; Rusconi C; Arcaini L; Rigacci L; Luminari S; Piccin A; Liu D; Wiestner A; Gaidano G; Cortelazzo S; Ladetto M; Gattei V
Haematologica; 2018 May; 103(5):849-856. PubMed ID: 29472356
[TBL] [Abstract][Full Text] [Related]
28. GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma.
Vater I; Wagner F; Kreuz M; Berger H; Martín-Subero JI; Pott C; Martinez-Climent JA; Klapper W; Krause K; Dyer MJ; Gesk S; Harder L; Zamo A; Dreyling M; Hasenclever D; Arnold N; Siebert R
Br J Haematol; 2009 Feb; 144(3):317-31. PubMed ID: 19016712
[TBL] [Abstract][Full Text] [Related]
29. Detailed assessment of copy number alterations revealing homozygous deletions in 1p and 13q in mantle cell lymphoma.
Flordal Thelander E; Ichimura K; Collins VP; Walsh SH; Barbany G; Hagberg A; Laurell A; Rosenquist R; Larsson C; Lagercrantz S
Leuk Res; 2007 Sep; 31(9):1219-30. PubMed ID: 17161458
[TBL] [Abstract][Full Text] [Related]
30. microRNA expression profiles identify subtypes of mantle cell lymphoma with different clinicobiological characteristics.
Navarro A; Clot G; Prieto M; Royo C; Vegliante MC; Amador V; Hartmann E; Salaverria I; Beà S; Martín-Subero JI; Rosenwald A; Ott G; Wiestner A; Wilson WH; Campo E; Hernández L
Clin Cancer Res; 2013 Jun; 19(12):3121-9. PubMed ID: 23640973
[TBL] [Abstract][Full Text] [Related]
31. Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization.
Allen JE; Hough RE; Goepel JR; Bottomley S; Wilson GA; Alcock HE; Baird M; Lorigan PC; Vandenberghe EA; Hancock BW; Hammond DW
Br J Haematol; 2002 Feb; 116(2):291-8. PubMed ID: 11841429
[TBL] [Abstract][Full Text] [Related]
32. Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling.
Hartmann EM; Campo E; Wright G; Lenz G; Salaverria I; Jares P; Xiao W; Braziel RM; Rimsza LM; Chan WC; Weisenburger DD; Delabie J; Jaffe ES; Gascoyne RD; Dave SS; Mueller-Hermelink HK; Staudt LM; Ott G; Beà S; Rosenwald A
Blood; 2010 Aug; 116(6):953-61. PubMed ID: 20421449
[TBL] [Abstract][Full Text] [Related]
33. High incidence of unbalanced chromosomal changes in mantle cell lymphoma detected by comparative genomic hybridization.
Jarosová M; Papajík T; Holzerová M; Dusek L; Pikalová Z; Lakomá I; Raida L; Faber E; Divoká M; Vlachová S; Prekopová I; Novosadová A; Pospísilová H; Indrák K
Leuk Lymphoma; 2004 Sep; 45(9):1835-46. PubMed ID: 15223644
[TBL] [Abstract][Full Text] [Related]
34. Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes.
Korz C; Pscherer A; Benner A; Mertens D; Schaffner C; Leupolt E; Döhner H; Stilgenbauer S; Lichter P
Blood; 2002 Jun; 99(12):4554-61. PubMed ID: 12036888
[TBL] [Abstract][Full Text] [Related]
35. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.
Hutter G; Scheubner M; Zimmermann Y; Kalla J; Katzenberger T; Hübler K; Roth S; Hiddemann W; Ott G; Dreyling M
Genes Chromosomes Cancer; 2006 Feb; 45(2):203-10. PubMed ID: 16258956
[TBL] [Abstract][Full Text] [Related]
36. TP53 mutation is not an independent prognostic factor in patients with mantle cell lymphoma at advanced stage.
Dong HJ; Zhou LT; Fang C; Fan L; Zhu DX; Wang YH; Li JY; Xu W
Med Oncol; 2012 Sep; 29(3):2166-73. PubMed ID: 22057359
[TBL] [Abstract][Full Text] [Related]
37. Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines.
Camps J; Salaverria I; Garcia MJ; Prat E; Beà S; Pole JC; Hernández L; Del Rey J; Cigudosa JC; Bernués M; Caldas C; Colomer D; Miró R; Campo E
Leuk Res; 2006 Aug; 30(8):923-34. PubMed ID: 16448697
[TBL] [Abstract][Full Text] [Related]
38. Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV.
de Vos S; Krug U; Hofmann WK; Pinkus GS; Swerdlow SH; Wachsman W; Grogan TM; Said JW; Koeffler HP
Diagn Mol Pathol; 2003 Mar; 12(1):35-43. PubMed ID: 12605034
[TBL] [Abstract][Full Text] [Related]
39. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
[TBL] [Abstract][Full Text] [Related]
40. Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques.
Salaverria I; Espinet B; Carrió A; Costa D; Astier L; Slotta-Huspenina J; Quintanilla-Martinez L; Fend F; Solé F; Colomer D; Serrano S; Miró R; Beà S; Campo E
Genes Chromosomes Cancer; 2008 Dec; 47(12):1086-97. PubMed ID: 18709664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
